U.S. Radiation Oncology Market Worth $3.9 Billion By 2027

The U.S. radiation oncology market size is expected to reach USD 3.9 billion by 2027, expanding at a CAGR of 5.0%, according to a new report by Grand View Research, Inc. Increasing the prevalence of cancer and technological advancements in radiation oncology are some of the key factors responsible for market growth.

Advancements in technologies are anticipated to reduce the adverse effects of radiotherapy and improve its overall quality. In addition, newer therapies tend to be more efficient than their traditional counterparts. For instance, SBRT was found to be efficient in treating laryngeal cancer with only five treatment fractions, as per a clinical trial that is expected to be completed by 2021.

Advancements in radiation oncology can enable the delivery of a high dose to a target area without any damage to adjacent healthy tissues. This has increased the chances of localized tumor control and improved cure rates, leading to an increase in demand for the therapy. Therefore, hospitals and ambulatory healthcare providers are installing more equipment, which, in turn, is boosting the market growth.

For instance, according to OECD, in the U.S., the number of radiotherapy equipment, which included linear accelerators, Caesium-137 therapy units, Cobalt-60 units, HDR and LDR brachytherapy units, and conventional brachytherapy units, was 11.7 per 1000,000 inhabitants in 2019.

In addition, increasing radiotherapy centers in the U.S. is anticipated to boost the market growth. In January 2020, the University of Alabama at Birmingham inaugurated its proton therapy center of Proton International. The center was formed through a partnership between Proton International and the UAB. Out of 36 proton cancer centers in the U.S., Proton International at UAB was the first facility opened in Alabama.

The high adoption of cyclotrons is anticipated to drive the market. For instance, in March 2019, the University of Alabama at Birmingham installed a 90-ton cyclotron in its proton therapy center. Installation of a cyclotron will drive R&D activities in the country and help meet the demand for isotopes.

Key players tend to undertake strategic initiatives such as collaborations, licensing, and partnerships to adopt new systems that can reduce cost and space; such initiatives are expected to drive the market. For instance, in June 2020, Accuray Incorporated launched the CyberKnife S7 System, which offers advanced technologies including real-time AI-driven motion tracking and synchronized treatment delivery. It can provide all SBRT treatments and Stereotactic Radio Surgeries (SRS) within 15 minutes.

Full Research Report On U.S. Radiation Oncology Market Visit Here: https://www.grandviewresearch.com/industry-analysis/us-radiation-oncology-market

The U.S. Radiation Oncology Market Report Highlights

• External Beam Radiotherapy (EBRT) dominated the market in 2019 owing to innovation in technology used in cancer treatment and an increase in the prevalence of cancer
• In 2019, Electron-emitting high energy linear accelerators held the largest revenue share as a result of an increase in usage due to technological revolution, an increase in capability to provide precise treatment services, and favorable reimbursement policies
• On the basis of technology, Intensity Modulated Radiotherapy (IMRT) dominated the application segment in 2019 due to its ability to change radiation intensity during treatment so as to specifically target cancer cells and limit the damage to adjoining healthy tissues
• In application, internal beam radiation therapy is estimated to witness the fastest growth rate during the forecast period owing to the cost-effectiveness and accuracy of brachytherapy.

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/us-radiation-oncology-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

U.S. Vaginal Moisturizers And Lubricants Market Worth $1.0 Billion By 2027

The U.S. vaginal moisturizers and lubricants market size is expected to reach USD 1.0 billion by 2027, expanding at a CAGR of 8.7% during the forecast period, based on a new report by Grand View Research, Inc. Market growth can be attributed to the increasing target population, growing demand for vaginal lubricants, and increasing awareness regarding sexual health among women. According to the Study of Women Across the Nation (SWAN), more than 2,400 women above the age of 17 and around 19.0% of women aged 42 to 53 suffer from vaginal dryness. Thus, increasing incidences of dryness is likely to drive the market for vaginal lubricants and moisturizers over the forecast period.

Various social media movements, such as the third wave of feminism, is aimed at breaking taboos around sexual health and assisting in changing the general attitude towards sex. Over the past few years, the sexual wellness market has shifted focus toward women’s products. Companies are offering conventional products with glamorous packaging, hence, helping to create more awareness around sexual health.

A considerable number of young people not aware of sexual health can increase the prevalence of STDs. September is considered as a sexual health awareness month in the U.S., which is expected to raise awareness among citizens about sexual health and wellness. A significant number of women suffer from vaginal dryness; however, they do not seek medical help, which is likely to hinder the market growth.

Full Research Report On U.S. Vaginal Moisturizers And Lubricants Market Visit Here: https://www.grandviewresearch.com/industry-analysis/us-vaginal-moisturizers-lubricants-market

U.S. Vaginal Moisturizers And Lubricants Market Report Highlights

• By distribution channel, retail dominated the market and is likely to witness the fastest growth over the forecast period
• An increasing number of fashion retailers are offering sexual wellness products, which is expected to introduce the younger generations to more sexual health and wellness products. A liberal lifestyle and social acceptance have led to the growth of adult stores around the country
• In November 2018, Durex formed a partnership with RED. This partnership was aimed at supporting its mission to end AIDS. Funds generated from the sale of the Durex RED condom were to be invested in South Africa where over 7.2 million people have HIV/AIDS
• Searchlight Pharma announced Fonds de solidarité FTQ and Emerillon Capital as the new strategic financial partners in October 2017. The partnership is expected to assist the growth of Searchlight Pharma.

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/us-vaginal-moisturizers-lubricants-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Oncology Companion Diagnostic Market Future Growth & Latest Trends

The global oncology companion diagnostic market size is expected to reach USD 5.7 billion by 2027, expanding at a CAGR of 12.7%, according to a new report by Grand View Research, Inc. Expanding access to important genomic information with the aid of companion diagnostics enables informed decision making for designing the targeted treatment approaches for their patients, thereby increasing demand for comprehensive genomic testing and oncology companion diagnostics.

The commercial launch of drugs including Gleevec (imatinib) and Herceptin (trastuzumab) that require Companion Diagnostics (CDx) testing before prescription has increased revenue generation in the oncology companion diagnostics field. This growth is expected to continue in the future owing to a substantial number of CDx associated oncology drugs in clinical trials. Apart from functioning as exclusive or inclusive tests for therapies, CDx also plays a crucial role during participant selection in clinical trials. This is because there is an increased potential for a novel drug candidate to show a better response rate if the patient has its biomarker target.

The economic incentives associated with the use of CDx have encouraged drug developers to combine their drugs with diagnostic tests. However, the diagnostic manufacturers face conflicting demands from payers/providers on one hand and drug manufacturers on the other hand. The regulatory bodies also have stringent policies to align the development timelines of diagnostics and drugs. Therefore, the diagnostic companies are expected to broaden their scope of CDx development instead of focusing on the attainment of a match between a single diagnostic with a specific drug.

Full Research Report On Oncology Companion Diagnostic Market Visit Here: https://www.grandviewresearch.com/industry-analysis/oncology-companion-diagnostics-market

Oncology Companion Diagnostic Market Report Highlights

• The product segment held the largest market share in 2019 owing to increased adoption and usage rate of CDx tests
• A significant increase in the approval rate of CDx and a rise in investments for co-development of drugs and their CDx is expected to increase the revenue generation in the product segment
• Consumables occupied a major share of the product segment owing to the frequent use and purchase of media, buffers, reagents, and other consumables required for CDx assay
• Immunohistochemistry (IHC) occupied a major portion of the technology segment owing to the benefits offered by IHC technology including cost and time effectiveness, the suitability of the technique for small tumor types, high adoption of IHC for routine oncology CDx, and low technological requirements associated with IHC
• Presence of a substantial number of FDA approved IHC based CDx assays such as EGFR pharmDx Kits, ER/PR pharmDx Kits, HercepTest Kits, PD-L1 IHC 28-8 pharmDx, VENTANA PD-L1 (SP142) Assay, VENTANA ALK (D5F3) CDx Assay, and VENTANA ALK IHC assay is also expected to increase revenue generation within the IHC segment
• The Non-Small Cell Lung Cancer (NSCLC) segment dominated the market in 2019 and is expected to maintain its dominance during the forecast period
• NSCLC is a lung cancer subtype that accounts for approximately 84.0% of all cases of lung cancer. According to data published by the American Cancer Society (ACS), in 2020, around 228,820 new cases of lung cancer are projected to be diagnosed in the U.S.
• The breast cancer and leukemia segments are expected to grow with substantial rates owing to a rise in the number of cancer cases
• The hospital segment held the largest share in the market in 2019 and is expected to exhibit a considerable growth rate, owing to a rise in the number of cancer diagnostic tests in the hospitals
• North America dominated the market in 2019 owing to the presence of a substantial number of players in this region, as well as the presence of a large number of FDA-approved CDx solutions in cancer therapeutics
• Advancements in technologies and improvements in the economic condition are anticipated to drive the market at the fastest growth rate in the Asia Pacific
• The presence of communities in Asian countries that are actively involved in monitoring and discovery of genetic biomarkers is expected to positively influence the market
• The key players in the market are involved in mutually beneficial partnerships with global entities, including sponsors and diagnostic commercialization partners, which enables them to leverage their market potential globally.

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/oncology-companion-diagnostics-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

Active Wheelchair Market Size Worth $2.3 Billion By 2027

The global active wheelchair market size is expected to reach USD 2.3 billion by 2027, expanding at a CAGR of 4.4%, according to a new report by Grand View Research, Inc. Surge in the geriatric and disabled population along with the rising prevalence of chronic diseases in the geriatric population are some of the key factors propelling the market growth.

Aging usually reduces the ability to move and perform physical tasks to maintain independent functioning. The increasing geriatric population is likely to create more demand for active wheelchairs over the forecast period. Moreover, they are more prone to falls, which can cause fatal or non-fatal injuries. The Western Europe region has the highest fall-related incidence and mortality rates in aged people. As per a research article published by Injury Prevention, in 2017, around 11.7 million aged people sought medical attention due to an injury, of which 8.4 million were owing to fall-related injuries. An increasing number of elderly people and rising incidents of falls in the elderly are projected to drive demand for active wheelchairs during the forecast period.

The introduction of technologically advanced active wheelchairs is also expected to drive the market as it provides more comfort to the users. In addition, increasing government initiatives to support the elderly and disabled population is boosting the market. For instance, the U.S. government provides various disability services to its citizens such as insurance for short-term and long-term disability, financial assistance & support services for the disabled, and education & jobs for persons with disabilities. In 2017, the Government of India offered free eldercare assistive devices under RashtriyaVayoshriYojana (RVY) to senior citizens belonging to lower economic strata of the country.

Furthermore, favorable reimbursement policies for the purchase of active wheelchairs, rising incidence of accidents, increasing spending on healthcare infrastructure, and increasing obese population across the globe due to drastic changes in daily lifestyle are also anticipated to propel the growth of the market.

Full Research Report On Active Wheelchair Market Visit Here: https://www.grandviewresearch.com/industry-analysis/active-wheelchair-market

Active Wheelchair Market Report Highlights

• The manual wheelchairs segment was the largest segment in 2019 owing to the low cost of the product and continuous technological advancement to meet the increasing demand in the emerging countries
• The powered wheelchairs segment is expected to register higher CAGR over the forecast period owing to an increase in product demand especially in developed countries such as the U.S. and Germany
• Cerebral Palsy was the largest indication segment in 2019 owing to the higher global prevalence of the condition and support offered by the active wheelchairs to the patient with cerebral palsy
• Europe dominated the market in 2019 with a 33.5% revenue share due to an increase in healthcare expenditure and growing geriatric and disabled population in the region
• Asia Pacific is expected to register a higher CAGR over the forecast period owing to rising awareness levels and increasing disposable income in the region.

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/active-wheelchair-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

Meningococcal Vaccine Market Driven By Increasing Prevalence Of Meningitis By 2027

The global meningococcal vaccine market size is expected to reach USD 5.9 billion by 2027, expanding at a CAGR of 9.5%, according to a new report by Grand View Research, Inc. Increasing prevalence of meningitis is one of the major factors attributed to the market growth. Furthermore, according to the European Centre for Disease Prevention and Control (ECDC), it was estimated that in 2017, 3,221 confirmed cases were observed in the EU member states, in which 58% of cases were found in the U.K., France, Spain, and Germany.

In addition, manufacturers are receiving Break Through Designation (BTD) for the development of improved vaccines as compared to available therapy. For instance, in February 2018, GlaxoSmithKline plc received BTD for Bexsero for extending its use in the age group below 11 years. Such initiatives are expected to improve meningococcal prevention, which in turn is anticipated to drive the market.

Initiatives undertaken by the government to combat the rising incidence of the disease is anticipated to boost the market growth. For instance, from April 2019, Nimenrix was made available for free as a part of the National Immunisation Program (NIP) for the age group 14 to 16 years. Nimenrix is a single dose quadrivalent meningococcal vaccine that targets serogroups A, C, W & Y.

In addition, rising awareness programs focused on prevention of the target disease is expected to fuel market growth. For instance, in April 2019, the National Day of Action against Meningitis B was launched by the Meningitis B Action Project on World Meningitis Day to improve awareness of meningitis regarding available vaccines such as MenACWY and MenB among healthcare professional, students, and parents.

Furthermore, the government provision of free vaccination to reduce the spread of the target disease is anticipated to boost the market growth. For instance, in November 2018, the government of New Zealand started a free vaccination program in Northland for infants and children.

Non-profit organizations entering into strategic initiatives such as partnering, alliances, and others to improve access to new vaccines for vulnerable children is anticipated to drive the market. For instance, Gavi is a vaccine alliance formed between UNICEF, World Health Organization, the Bill and Melinda Gates Foundation, and the World Bank to help boost economies of low-income countries and improve access to under-used vaccines for children suffering from meningitis.

Moreover, clinical trials conducted on teenagers to develop novel meningococcal vaccines are expected to drive the market. For instance, in March 2018, the National Health Service launched a Meningitis B vaccine trial for teenagers and recruited 24,000 volunteers of age group 16 to 18 years for this study. This clinical trial was funded and supported by the National Institute for Health Research (NIHR).

The availability of vaccines at lower prices in countries with an increasing prevalence of meningococcal diseases is anticipated to fuel the revenue of the manufacturers and drive the market. For instance, under the Meningitis Vaccine Project, MenAfriVac costs less than USD 0.5 per dose.

Full Research Report On Meningococcal Vaccine Market Visit Here: https://www.grandviewresearch.com/industry-analysis/meningococcal-vaccines-market

Meningococcal Vaccine Market Report Highlights

• In 2019, Bexsero was the largest-revenue holding brand in the market owing to its stronger demand in Europe and studies showing a decrease in meningitis cases
• The quadrivalent segment is expected to witness the fastest growth over the forecast period due to its ability to target four serogroups and the availability of vaccines such as Menactra, Menveo, and Nimenrix
• In the case of the age group segment, infants (0 to 2 years) are expected to witness a significant CAGR owing to the increasing prevalence of meningitis in the age group 9 months to 11 years
• Asia Pacific is projected to witness the fastest growth during the forecast period owing to the high unmet needs and rising healthcare expenditure
• North America dominated the market in 2019 due to the presence of key players and rising initiatives to raise awareness among healthcare professionals and patients

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/meningococcal-vaccines-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Burn Ointment Market Size Is Projected To Reach $1.3 Billion By 2027

The global burn ointment market size is expected to reach USD 1.3 billion by 2027, expanding at a CAGR of 6.1%, according to a new report by Grand View Research, Inc. Rising cases of blaze wounds, technological advancements, and increasing awareness regarding various treatment options are the key factors driving the market.

Favorable government initiatives such as reimbursement policies which cover almost 70.0-100.0% of the treatment cost urge the patient to opt for advanced wound care treatment. The presence of government organizations such as the World Health Organization (WHO) and non-profit organizations like the American Burn Association (ABA) also contribute towards increasing awareness levels. The WHO has been collaboratively working with The International Society for Burn Injuries and other such organizations to develop strategies to improve wound care and prevention of blaze wounds globally. Furthermore, the presence of non-profit organizations such as the British Burn Association and the Canadian Association of Burn Nurses, which aim towards providing and propagating knowledge on best treatment and rehabilitation following a blaze wound is also increasing the awareness levels regarding wound care and treatment among people.

Increasing incidences of blaze wounds are anticipated to fuel the demand for cost-effective treatment over the forecast period. As per WHO, 96.0% of fatal fire-related wounds occur in low to middle-income countries. According to the data published by WHO, on an average 265,000 deaths are caused by blaze wounds every year. Such factors are anticipated to boost the market growth.

Full Research Report On Burn Ointment Market Visit Here: https://www.grandviewresearch.com/industry-analysis/burn-ointment-market

Burn Ointment Market Report HIghlights

• On the basis of product, topical antibiotics held the largest market share in 2019 as these ointments are used for every kind of blaze wound
• The minor burn segment held the largest market share in 2019 and is anticipated to witness significant growth over the forecast period. The growth of the segment is attributable to the high usage of ointments for minor blaze wounds as compared to other wounds
• The hospital segment is anticipated to witness significant growth over the forecast period owing to the increasing incidence of blaze wounds
• In Asia Pacific, the market is anticipated to witness the fastest growth over the forecast period owing to the rising cases of blaze wounds in this region.

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/burn-ointment-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Continuous Subcutaneous Insulin Infusion Market Growth & Trends

The global continuous subcutaneous insulin infusion market size is expected to reach USD 7.3 billion by 2027, registering a CAGR of 10.3% over the forecast period, according to a new report by Grand View Research, Inc. The key drivers of the market include increasing number of diabetes population coupled with technological advancement in the field of diabetes care.

According to International Diabetes Federation (IDF), the total number of diabetic population is expected to grow by 51.0% from 463.0 million in 2019 to 700.0 million in 2045. Rising health expenditure and growing awareness about preventive care is expected to boost market growth. According to the IDF, the estimated total global health expenditure to diabetes was USD 760.0 billion and is projected to grow to USD 845.0 billion by 2045. Furthermore, rising government initiatives to spread the awareness about diabetes is propelling the adoption of advanced diabetes management devices. Australian government launched Australian National Diabetes Strategy 2016 to 2020. The strategy aims to trace country’s national response to this epidemic and inform how existing limited healthcare can be better targeted across all level of government.

Increasing number of product launches and advent of artificial intelligence in the market is boosting the growth. Many startups are transforming CSII therapy. These companies are taking initiatives to lessen the burden of diabetes with help of AI technology. They are leveraging technological advancement to improve market solutions like integrated insulin pumps, non-invasive insulin delivery systems, and closed-loop artificial pancreases.

Full Research Report On Continuous Subcutaneous Insulin Infusion Market Visit Here: https://www.grandviewresearch.com/industry-analysis/continuous-subcutaneous-insulin-infusion-market

Continuous Subcutaneous Insulin Infusion Market Report Highlights

• North America accounted for the largest share in 2019 owing to favorable reimbursement policies, presence of key players, and frequent product launches
• Asia Pacific is expected to see robust growth during the forecast period owing to presence of large diabetic population
• By product, tethered pumps dominated the market owing to availability of products
• By patient type, type 1 patients account for the largest share owing wide usage of insulin pumps
• By end use, the hospitals segment dominated the market in 2019 and the homecare segment is expected to grow at a fastest pace
• The market is highly competitive owing to continuous technological advancement and many innovative product launches.

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/continuous-subcutaneous-insulin-infusion-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

 

U.S. Digital Therapeutics Market Future Growth & Trends

The U.S. digital therapeutics market size is expected to reach USD 5.47 billion by 2027, registering a CAGR of 22.2% during the forecast period, according to a new report by Grand View Research, Inc. Technological advancement in healthcare IT, increasing demand for integrated healthcare system, and cost effective patient care are driving the market growth.

COVID-19 pandemic has expedited the adoption of Digital Therapeutics (DTx) especially pertinent to mental illness and chronic ailments like diabetes and Cardiovascular Diseases (CVD). The U.S. Food and Drug Administration (FDA) released new guidelines for computerized behavioral therapy and other DTx solutions during this public health emergency. The organization has waived off guidelines that include 510(k) premarket notifications, registration and listing requirements, and Unique Device Identification (UDI) requirements for DTx therapeutic devices with low risk. For instance, Pear therapeutics launched Pear-004 for psychosis and self-management training post the new guidelines. The product needs to be used under a doctor’s supervision.

The need for cost-effective healthcare is increasing due to rising healthcare expenditure. Digital health technology is being encouraged and preferred to avoid unnecessary costs and promote cheaper & alternative means of healthcare delivery, thus propelling the market. Moreover, rising demand for remote monitoring services due to increasing incidence of chronic diseases worldwide is one of the factors propelling market growth. Digital therapeutic applications allow patients to manage and treat diseases without constant medical intervention, thereby drastically reducing healthcare expenditure.

Full Research Report On U.S. Digital Therapeutics Market Visit Here: https://www.grandviewresearch.com/industry-analysis/us-digital-therapeutics-market

U.S. Digital Therapeutics Market Report Highlights

• In terms of revenue, diabetes dominated the application segment in 2019. The growth can be attributed to increasing incidence of this diseases and demand for self-management and constant monitoring
• On basis of end use, patients held the largest revenue share in 2019 owing to increased adoption of healthcare IT services through Artificial Intelligence (AI) driven smartphone apps
• In the wake of COVID 19 pandemic, patients with chronic diseases are facing challenges in managing medications, visiting healthcare providers, and maintaining a balanced diet. DTx therapy can be useful in managing patient conditions remotely
• Companies such as DarioHealth, WellDoc, and Kaia Health are providing guidance to diabetic patients for managing their glucose levels and maintaining a healthy lifestyle
• In January 2020, Pear Therapeutics and Crossroads Treatment Centers entered into a partnership to incorporate reSET-O PDT in several opioid use disorder treatment centers located in Pennsylvania, thereby enhancing its market reach

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/us-digital-therapeutics-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

 

Endotracheal Tubes Market Size Worth $2.9 Billion By 2027

The global endotracheal tubes market size is expected to reach USD 2.9 billion by 2027, expanding at a CAGR of 6.0%, according to a new report by Grand View Research, Inc. The rising prevalence of chronic diseases such as respiratory, cardiovascular diseases, and increasing number of surgical procedures, are expected to propel market growth. In addition,technological development in the medical device is further expected to contribute to market growth during forecast period. Recently Medtronic has launched a Shiley laser oral endotracheal tubes that are most widely used for ventilation during CO2 and KTP laser surgeries of the laryngeal or tracheal area.

Moreover,growing need for ventilator associated with pneumonia and increasing geriatric population that are prone to chronic diseases is one of the important factors responsible for market growth during assessment period. As per World Health Organization Report 2019, 4.0 million people die prematurely due to chronic respiratory disease. Due to increasing air pollution the prevalence of respiratory diseases is also increasing. According to World Health Organization Report 2019, around 2.0 billion people are exposed to indoor toxic, 1.0 billion people are exposed to outdoor pollutant air, and around 1.0 billion people are exposed to tobacco smoke. Above factors are likely to boost market growth. In addition, increasing awareness about technologically advanced medical devices, and developments in the field of nanobiotechnology and drug design are some of the factors responsible for market growth.

North America accounted for the highest market share in 2019 owing to the advanced healthcare system and the growing prevalence of chronic diseases in the country. In addition, the presence of major players in the region contributed to market growth.

Full Research Report On Endotracheal Tubes Market Visit Here: https://www.grandviewresearch.com/industry-analysis/endotracheal-tubes-market

Endotracheal Tubes Market Report Highlights

• By product type, the regular endotracheal tube segment held the largest market share of 32% in 2019 owing to increasing prevalence of respiratory diseases
• Orotracheal segment held the largest market share accounted for 64% in 2019 owing to its high applicability, increased usage and comfortability
• North America dominated the market in 2019. Rising prevalence of chronic respiratory disease is one of the major factors driving the market growth in this region
• Asia Pacific is expected to witness the fastest growth over the forecast period. As the healthcare infrastructure in the region is developing resulting in increased number of surgeries being performed and eventually fueling the growth of the market.

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/endotracheal-tubes-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Europe Mobility Aids Market Future Growth & Latest Demand

The Europe mobility aids market size is expected to reach USD 3.7 billion by 2027, expanding at a CAGR of 3.8%, according to a new report by Grand View Research, Inc. High demand for home healthcare and an increase in the geriatric population requiring long term care are expected to propel market growth over the forecast period. In addition, technological advancements in mobility aids are also expected to increase adoption, thereby contributing to market growth.

The introduction of new mobility aids by market players is anticipated to increase the number of products available in the market and facilitate market growth. For instance, in 2017, Drive DeVilbiss introduced the Panther Heavy-duty 4-wheel scooter and Cruise II wheelchair, thus expanding the company’s product portfolio and driving the market growth.

Furthermore, the aging population in the U.K. has increased significantly in the past five decades. As per statistics published by Age U.K., in 2017, around 11.8 million people in the U.K. were aged 65 years or over. Moreover, around 4.0 million older citizens in the U.K. were estimated to suffer from a long-term illness, and these health conditions severely affected their mobility. The increasing geriatric population is a vital impact rendering driver for the market.

In addition, the availability of a variety of funding systems for Long-term Care (LTC), such as social insurance, private insurance, and universal health coverage scheme, across the European nations is also anticipated to significantly improve the affordability of mobility devices. In addition, the tax-based system in England is also focusing on the provision of rehabilitation and reablement services to patients. These factors are expected to result in lucrative growth of the market through the forecast period. 

Full Research Report On Europe Mobility Aids Market Visit Here: https://www.grandviewresearch.com/industry-analysis/europe-mobility-aid-market

Europe Mobility Aids Market Report Highlights

• The wheelchair segment spearheaded the market in 2019 due to an increasing number of disorders, such as spinal cord injuries, which require wheelchair support
• The public segment was the largest in terms of revenue due to the presence of established players in the market offering a wide range of products
• The aged care segment dominated the market in 2019, with a revenue share of more than 50.0% attributed to increasing in geriatric population in the region

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/europe-mobility-aid-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Pupillometer Market Growth & Trends

The global pupillometer market size is expected to reach USD 543.7 million by 2027, expanding at a CAGR of 5.2%, according to a new report by Grand View Research Inc. The adoption of pupillometry is on the rise as an assessment examination for diagnosing various health conditions. This growth in its adoption is leading to the development of advanced pupillometer devices for a faster and accurate diagnosis. Research has shown that a large number of neurological disorders have a direct impact on pupil size and hence can be diagnosed through pupillometry exam. Moreover, understanding the changes occurring in pupil characteristics helps clinicians in performing various neurological surgeries.

Pupillometers are widely being used in critical care units, as pupillometry is becoming a protocol for primary diagnosis. The Pupillary Light Reflex (PLR) acts as an indication and clinical parameter for diagnosing various diseases. Since the demand for the pupillometer is increasing, many nursing centers, educational centers, and research centers are providing training regarding pupillometry. This training helps in increasing the number of skilled professionals. Pupillometry is becoming pre-requisite in many settings, therefore, companies are developing integrated devices with pupillometry to provide settings such as hospitals with the all-in-one device.

Market players are participating in trade shows, exhibitions, and are conducting conferences to increase awareness regarding pupillometry and reach of their pupillometers. Additionally, these market players are developing handheld devices to resolve the issue of mobility and to increase the accessibility of the device in various settings. Moreover, companies have come up with technologically advanced software that can be installed on mobile to complete the process of pupillometry through mobile.

Video pupillometers are preferred more as they can be used in capturing the entire procedure of pupil dilation in a much detailed manner. The device helps in capturing the pupil characteristic and its reactivity over time, which in turn is expected to enhance the diagnosis process. On the other hand, the development of a digital pupillometer is gaining momentum. The device comes along with various advantages such as mobility, accuracy, instant results, and efficiency. These devices help in conducting the rapid assessment, which, in turn, is expected to boost the overall market growth.

Full Research Report On Pupillometer Market Visit Here: https://www.grandviewresearch.com/industry-analysis/pupillometer-market

Pupillometer Market Report Highlights

• The table-top segment held the largest revenue share in 2019 as market players are focusing to develop integrated pupillometer devices along with keratometer, pachymeters, and wavefront aberrometer
• The hand-held segment is expected to grow at the fastest rate during the forecast period owing to its easy accessibility and accuracy
• The digital segment is expected to grow at the fastest rate as these devices provide instant and accurate results
• The hospitals segment held the largest revenue share in 2019 due to the growing installation of pupillometer in this setting
• The eye clinics segment is expected to grow at the fastest rate during the forecast period due to the growing adoption of pupillometry in various ophthalmic clinics
• The ophthalmology segment held the largest share in 2019 owing to the growing usage of pupillometry in understanding damage on the inner and outer retina
• North America held the largest revenue share in 2019 owing to the increasing prevalence of vision-related problems in the regions and growing awareness and adoption of pupillometry
• Asia Pacific is expected to experience the fastest growth rate during the forecast period mainly due to increasing availability of pupillometer through online platforms and suppliers

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/pupillometer-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com